Abstract: The solar array (SA) serves as the sole energy source for satellites, continuously converting sunlight into electricity to power satellite operations. Sensors placed at key locations on the ...
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Miami-based real estate ...
After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...
The Journal Sentinel's John Steppe discusses Wisconsin's 74-63 loss to TCU in the Rady Children's Invitational championship game. Jorge Polanco reportedly agrees to 2-year, $40 million deal with Mets ...
Journal Sentinel preps reporter Zac Bellman previews the matchups of seven area football teams still alive in the WIAA playoffs entering Nov. 14. From Fernando Mendoza's performance against the Ducks ...
Christmas and cookies go together like Thanksgiving and turkey, and the Journal Sentinel wants to help spread the festive cheer. We're running a list of area cookie sales in our Food section on Dec. 3 ...
After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...
Recursion Pharmaceuticals currently has the industry's largest AI supercomputer. It also has partnerships with major drugmakers, but these have yet to yield major wins. Recursion'a lack of clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback